Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

PureTech (PRTC) Share Price

Price 128.00p on 23-12-2025 at 09:10:11
Change 1.20p 0.95%
Buy 127.40p
Sell 126.40p
Last Trade: Buy 7.00 at 128.00p
Day's Volume: 787
Last Close: 126.80p
Open: 128.00p
ISIN: GB00BY2Z0H74
Day's Range 128.00p - 128.00p
52wk Range: 100.40p - 160.00p
Market Capitalisation: £309.36m
VWAP: 128.00p
Shares in Issue: 241.68m

PureTech (PRTC) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 7 128.00p SI Trade
08:00:37 - 23-Dec-25
Buy* 80 128.00p SI Trade
08:00:37 - 23-Dec-25
Buy* 700 128.00p Suspected BUY Trade
08:00:22 - 23-Dec-25
Sell* 10,000 126.80p Ordinary
16:35:34 - 22-Dec-25
Sell* 42,404 126.80p Uncrossing Trade
16:35:24 - 22-Dec-25
Sell* 1,633 126.20p Automatic Execution
16:27:58 - 22-Dec-25
Sell* 2,164 126.60p Automatic Execution
16:27:58 - 22-Dec-25
Sell* 39 126.60p Automatic Execution
16:27:58 - 22-Dec-25
Buy* 122 127.00p Automatic Execution
16:27:18 - 22-Dec-25
Buy* 62 127.00p Automatic Execution
16:27:18 - 22-Dec-25
See more PureTech trades

PureTech (PRTC) Share Price History

Time period:
to
Date Open High Low Close Volume
23rd Dec 2025 (Tue) 128.00 128.00 128.00 126.80 787
22nd Dec 2025 (Mon) 128.00 128.00 125.00 126.80 233,220
19th Dec 2025 (Fri) 125.00 126.80 124.20 126.00 238,480
18th Dec 2025 (Thu) 120.00 125.40 120.00 125.00 369,468
17th Dec 2025 (Wed) 121.20 121.20 120.00 120.60 130,558
16th Dec 2025 (Tue) 123.00 123.00 120.60 121.00 1,134,432
15th Dec 2025 (Mon) 122.00 123.60 121.80 122.20 217,525
12th Dec 2025 (Fri) 123.00 124.80 122.00 122.00 704,285
11th Dec 2025 (Thu) 120.40 123.00 120.00 123.00 1,042,919
10th Dec 2025 (Wed) 125.00 125.20 121.80 123.20 268,055
9th Dec 2025 (Tue) 125.40 126.00 123.80 125.60 292,905
8th Dec 2025 (Mon) 125.00 128.20 123.20 123.80 876,410
5th Dec 2025 (Fri) 122.40 123.20 121.20 122.00 144,825
4th Dec 2025 (Thu) 123.00 123.00 119.20 122.20 569,006
3rd Dec 2025 (Wed) 120.00 120.60 119.20 120.20 204,862
2nd Dec 2025 (Tue) 125.00 125.00 121.60 122.00 126,525
1st Dec 2025 (Mon) 123.40 124.80 123.00 124.80 125,434
28th Nov 2025 (Fri) 128.00 128.00 124.00 126.00 58,462
27th Nov 2025 (Thu) 125.00 127.00 124.40 125.60 327,112
26th Nov 2025 (Wed) 124.20 124.60 122.80 124.60 206,488
25th Nov 2025 (Tue) 125.80 125.80 122.00 123.80 173,207
24th Nov 2025 (Mon) 123.40 123.40 121.40 123.20 174,295
See more PureTech price history

PureTech (PRTC) Regulatory News

Date Source Headline
18th Dec 2025 7:00 am RNS PureTech Appoints Robert Lyne as CEO
10th Dec 2025 5:41 pm RNS Results of AGM on June 16, 2025 – Update Statement
10th Dec 2025 5:30 pm RNS Holding(s) in Company
8th Dec 2025 7:00 am RNS-R PRTC: Successful FDA Meeting; IPF Phase 3 in 1H26
5th Dec 2025 6:00 pm RNS-R PRTC's Gallop: Positive Initial Topline AML Data
18th Nov 2025 5:30 pm RNS Holding(s) in Company
7th Nov 2025 6:18 pm RNS Holding(s) in Company
3rd Nov 2025 2:00 pm RNS-R PRTC: New LYT-200 AML Data + Update at ASH
22nd Oct 2025 7:00 am RNS-R PRTC: New IPF Data Show Benefit in Older Patients
17th Oct 2025 5:30 pm RNS Holding(s) in Company
See more PureTech regulatory news

PureTech (PRTC) Share News

IN BRIEF: PureTech Health promotes interim CEO Robert Lyne to CEO

18th Dec 2025 11:11

PureTech Health PLC - Boston, Massachusetts-based biotech and pharmaceutical firm - Promotes interim Chief Executive Officer Robert Lyne to CEO on a permanent basis from Thursday. Lyne has served as interim CEO since July, having joined the company in January 2024 as chief portfolio officer. He has overseen progress across PureTech's programmes and advancing strategic and operational priorities. Lyne was previously CEO of Arix Bioscience PLC. Read More

FDA backs PureTech's phase 3 move for IPF drug deupirfenidone

8th Dec 2025 12:34

(Alliance News) - PureTech Health PLC on Monday said its idiopathic pulmonary fibrosis drug candidate deupirfenidone has cleared a key regulatory milestone, with the US Food & Drug Administration backing progression into a pivotal phase 3 trial planned for the first half of 2026. Read More

SMALL-CAP WINNERS: Mears rises as annual profit set to beat forecasts

8th Dec 2025 10:59

(Alliance News) - The following stocks are the leading risers among London Main Market small-caps on Monday. Read More

TRADING UPDATES: London BTC continues work towards Nasdaq listing

5th Dec 2025 21:58

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

DIRECTOR DEALINGS: PureTech Health team buy GBP300,000 in shares

24th Sep 2025 12:15

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced in the past week and not separately reported by Alliance News: Read More

See more PureTech news
FTSE 100 Latest
Value9,870.57
Change4.60

Login to your account

Forgot Password?

Not Registered